5th NASH Roundtable™ Virtual Forum
Thursday June 16, 2022 at 11:30 AM PDT / 02:30 PM EDT

More information »


Fact Sheet: NASH Roundtable™, leading clinical development experts addressing challenges in NASH drug development

View Fact Sheet »


June 2022

Noninvasive Diagnosis of Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis Using Machine Learning Methods: Comparative Study With Existing Quantitative Risk Scores Read More »

June 2022

Breakthroughs in therapies for NASH and remaining challenges Read More »

May 2022

Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool Read More »

May 2022

The Effect of Diabetes and Prediabetes on the Prevalence, Complications and Mortality in Non-alcoholic Fatty Liver Disease Read More »